Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development of Treatment Methods

Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development of Treatment Methods

Dystroglycanopathy is a collective term referring to muscular dystrophies with abnormal glycosylation of dystroglycan. At least 18 causative genes of dystroglycanopathy have been identified, and its clinical symptoms are diverse, ranging from severe congenital to adult-onset limb-girdle types. Moreo...

Full description

Bibliographic Details
Main Author: Motoi Kanagawa
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
muscular dystrophy
glycosylation
dystroglycan
therapy
model mouse
ribitol-phosphate
Online Access:https://www.mdpi.com/1422-0067/22/23/13162

Internet

https://www.mdpi.com/1422-0067/22/23/13162

Similar Items